prednisone has been researched along with imatinib mesylate in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (44.19) | 29.6817 |
| 2010's | 21 (48.84) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brandwein, J; Gupta, V; Kamel-Reid, S; Lipton, JH; Messner, HA; Minden, MD | 1 |
| Chamone, Dde A; Conchon, M; Dorlhiac-Llacer, PE; Fonseca, GH; Novaretti, MC | 1 |
| Bauer, H; Frickhofen, N; Hochhaus, A; Jung, B; Märker-Hermann, E; Reiter, A; Walz, C | 1 |
| Amabile, M; Baccarani, M; Gaitani, S; Malagola, M; Martinelli, G; Paolini, S; Piccaluga, PP; Rondoni, M; Soverini, S; Visani, G | 1 |
| Ottmann, OG; Wassmann, B | 1 |
| Nathan, SD | 1 |
| Bruijnzeel-Koomen, CA; Lokhorst, HM; van Ruth, S | 1 |
| Boccadoro, M; Campa, E; Dellacasa, C; Fava, C; Ferrero, D; Fumagalli, M; Mattioli, G; Perfetti, P; Pogliani, EM; Rege-Cambrin, G | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Hoyer, R; Krook, J; LeMarbre, G; Schinstock, C; Tefferi, A | 1 |
| Besson, C; Buffet, C; Dhalluin-Venier, V; Dimet, S; Tchernia, G; Thirot-Bibault, A | 1 |
| Amariglio, N; Ashur-Fabian, O; Ellis, MH; Trakhtenbrot, L | 1 |
| Bruguera, M; Fuster, F; Granell, M; Medina, L; Vallansot, R | 1 |
| Dahabreh, IJ; Giannouli, S; Moutsopoulos, HM; Voulgarelis, M; Zoi, C; Zoi, K | 1 |
| Cogan, E; Roufosse, F | 1 |
| Auclerc, MF; Baruchel, A; Cayuela, JM; Chevret, S; Debre, M; Demeocq, F; Gandemer, V; Jonveaux, P; Le Gall, E; Lejars, O; Leverger, G; Perel, Y; Piguet, C; Schmitt, C; Stephan, JL; Vannier, JP | 1 |
| Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D | 1 |
| Hamerschlak, N; Kerbauy, FR; Mac-Donald Bley do Nascimento, C; Mauro Kutner, J; Ribeiro, AA; Rodrigues, M; Santos, FP | 1 |
| Butterfield, JH; Li, CY; Lim, KH; Pardanani, A; Tefferi, A | 1 |
| Hutyra, M; Kozák, J; Lukl, J; Szotkowski, T; Táborský, M; Václavík, J | 1 |
| Chu, DT | 1 |
| Cheung, WY; Ksienski, D | 1 |
| Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ | 1 |
| Bhatt, VR; Gupta, S; Varma, S | 1 |
| Abella, E; Amigo, ML; Barrios, M; Bravo, P; Brunet, S; García, O; González-Campos, J; Hernández-Rivas, JM; Montesinos, P; Ribera, JM | 1 |
| Kravchenko, SK; Moiseyeva, TN; Sharkunov, NN; Vinogradova, OY; Zybunova, EE | 1 |
| Burger, JA; Challagundla, P; Champlin, RE; Cortes, JE; Estrov, Z; Faderl, S; Ferrajoli, A; Garris, R; Huang, X; Jorgensen, JL; Kantarjian, HM; Kebriaei, P; Luthra, R; O'Brien, S; Ravandi, F; Thomas, DA; Wang, SA; Wen, S | 1 |
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Koh, K | 1 |
| Berenguer-Potenciano, M; Camacho-Salas, A; Nunez-Enamorado, N; Perez-Alonso, V; Simon-De Las Heras, R; Villora-Morcillo, N | 1 |
| Baird, K; Booher, S; Comis, LE; Cowen, EW; Figg, WD; Flanders, KC; Hakim, FT; Joe, GO; Mitchell, SA; Pavletic, SZ; Rose, JJ; Sarantopoulos, S; Steinberg, SM; Takebe, N; Yao, L | 1 |
| Huang, QR; Jia, YQ; Jiang, NG; Jin, YM; Li, HF; Li, X; Meng, WT; Mo, XM; Xu, H; Zeng, TT | 1 |
| Barbetseas, J; Benetos, G; Bonou, M; Diamantopoulos, P; Giannakopoulou, N; Kapelios, CJ; Korkolopoulou, P; Moyssakis, I; Variami, E | 1 |
| Cortelezzi, A; Fracchiolla, NS; Sciumè, M | 1 |
| Ben-Ami, E; Castells, MC; Connell, NT; Rutherford, AE; Thornton, KA | 1 |
| Dmytrenko, IV; Dyagil, IS; Fedorenko, VG; Martina, ZV; Minchenko, ZM; Shlyakhtychenko, TY; Sholoyko, VV; Silayev, YO; Tovstogan, AO | 1 |
| Huang, J; Jin, F; Ouyang, G; Pan, J; Zhang, P | 1 |
| Chinen, Y; Fujino, T; Horiike, S; Isa, R; Kawaji, Y; Kobayashi, T; Kohno, K; Kuroda, J; Kuwahara-Ota, S; Nakamura, S; Nishiyama, D; Shimura, Y; Tsukamoto, T; Yamaguchi, J | 1 |
| Jin, J; Li, XY; Meng, HT; Qian, JJ; Tong, HY; Wang, SS; Yang, M; Ye, XJ; Yu, WJ; Zhang, Y; Zhu, HH | 1 |
| Cao, W; Jiang, Z; Li, L; Li, X; Li, Y; Wan, D; Yu, J; Zhang, S | 1 |
| Alexandre, PA; Brandão, PE; Casagrande, TAC; Dagli, MLZ; de Queiroz, GF; Fukumasu, H; Macedo, TR; Matera, JM; Melo, SR; Pinto, ACBCF | 1 |
4 review(s) available for prednisone and imatinib mesylate
| Article | Year |
|---|---|
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Topics: Acetylcysteine; Azathioprine; Benzamides; Bosentan; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Imatinib Mesylate; Immunoglobulin G; Interferon-gamma; Piperazines; Prednisone; Pulmonary Fibrosis; Pyridones; Pyrimidines; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
[Imatinib-induced toxic hepatitis: description of two cases and review of the literature].
Topics: Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Prednisone; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Stomach Neoplasms; Time Factors | 2007 |
[Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Doxorubicin; Drug Delivery Systems; ErbB Receptors; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Mutation; Neoplasms; Piperazines; Prednisone; Pyrimidines; Pyrroles; Remission Induction; Rituximab; Sunitinib; Vincristine | 2010 |
[Current treatment of pediatric acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child, Preschool; Clinical Trials as Topic; Cytarabine; Dexamethasone; Drug Discovery; Humans; Imatinib Mesylate; Induction Chemotherapy; Mercaptopurine; Methotrexate; Molecular Targeted Therapy; Neoplasm, Residual; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines | 2014 |
4 trial(s) available for prednisone and imatinib mesylate
| Article | Year |
|---|---|
Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cytogenetic Analysis; Female; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Patient Selection; Piperazines; Prednisone; Prospective Studies; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Translocation, Genetic | 2007 |
Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
Topics: Acute Disease; Adolescent; Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Cortisone; Female; Humans; Imatinib Mesylate; Infant; Leukocyte Count; Male; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Recurrence; Treatment Outcome; Vincristine; Young Adult | 2009 |
Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Imatinib Mesylate; Male; Mercaptopurine; Methotrexate; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vincristine; Young Adult | 2012 |
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Administration Schedule; Fasciitis; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Joints; Leukemia; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisone; Range of Motion, Articular; Recurrence; Skin Diseases; Tacrolimus; Transplantation, Homologous | 2015 |
35 other study(ies) available for prednisone and imatinib mesylate
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Hepatitis B; Humans; Imatinib Mesylate; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Salvage Therapy; Vincristine | 2003 |
First case of immune-mediated haemolytic anaemia associated to imatinib mesylate.
Topics: Anemia, Hemolytic; Benzamides; Coombs Test; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Piperazines; Prednisone; Pyrimidines | 2003 |
Complete molecular remission of chronic eosinophilic leukemia complicated by CNS disease after targeted therapy with imatinib.
Topics: Adult; Antineoplastic Agents; Arm; Azathioprine; Benzamides; Brain; Cerebellar Ataxia; Cerebellar Cortex; Enzyme Inhibitors; Headache; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Immunosuppressive Agents; Leukemic Infiltration; Magnetic Resonance Imaging; Male; Memory Disorders; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Paresis; Parietal Lobe; Piperazines; Polyarteritis Nodosa; Prednisone; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Vertigo | 2004 |
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Doxorubicin; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Stem Cell Transplantation; Transplantation, Homologous; Vincristine | 2004 |
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Clinical Trials as Topic; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Neoplasm, Residual; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Stem Cell Transplantation; Survival Rate | 2005 |
[Two patients with hypereosinophilic syndrome].
Topics: Adult; Benzamides; Diagnosis, Differential; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Interferon-alpha; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Prednisone; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Stem Cell Transplantation | 2006 |
Corticosteroids can reverse severe imatinib-induced hepatotoxicity.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Liver Diseases; Methylprednisolone; Piperazines; Prednisone; Pyrimidines | 2006 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate.
Topics: Anemia, Aplastic; Benzamides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Immunoglobulins; Injections, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Prednisone; Pyrimidines; Time Factors; Treatment Outcome | 2007 |
Imatinib mesylate-induced acute hepatitis with autoimmune features.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents; Antiviral Agents; Benzamides; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Function Tests; Piperazines; Polyethylene Glycols; Prednisone; Pyrimidines; Recombinant Proteins | 2006 |
A clonal hypereosinophilic syndrome with specific and effective therapy: a report of two cases.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Biomarkers; Diagnosis, Differential; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; Middle Aged; Mutation; Piperazines; Prednisone; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Treatment Outcome | 2006 |
[Practical approach to hypereosinophilia].
Topics: Benzamides; Eosinophils; Food Hypersensitivity; Glucocorticoids; Hematologic Diseases; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Mutation; Neoplasms; Parasitic Diseases; Piperazines; Prednisone; Protein-Tyrosine Kinases; Pulmonary Eosinophilia; Pyrimidines | 2008 |
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult | 2009 |
Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib.
Topics: Aged; Antineoplastic Agents; Benzamides; Blast Crisis; Dasatinib; Hematopoietic Stem Cell Transplantation; Humans; Iatrogenic Disease; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protein Kinase Inhibitors; Pyrimidines; Remission Induction; Thiazoles; Treatment Outcome | 2010 |
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Bone Marrow; Cladribine; Dioxygenases; DNA Mutational Analysis; DNA-Binding Proteins; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Janus Kinase 2; Male; Mast Cells; Mastocytosis, Systemic; Middle Aged; Mutation, Missense; Piperazines; Point Mutation; Prednisone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.
Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Benzamides; Drug Therapy, Combination; Endocarditis; Eosinophils; Heart; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Prednisone; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Thrombosis; Treatment Outcome; Warfarin | 2010 |
Metastatic uterine leiomyosarcoma and eosinophilia.
Topics: Antineoplastic Agents; Benzamides; Dyspnea; Eosinophilia; Fatal Outcome; Female; Humans; Hydroxyurea; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Middle Aged; Piperazines; Prednisone; Pyrimidines; Splenic Neoplasms; Uterine Neoplasms | 2011 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine | 2012 |
Recurrent imatinib-induced hepatotoxicity in a chronic myeloid leukaemia patient successfully managed with prednisone.
Topics: Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Prednisone; Pyrimidines; Recurrence; Remission Induction; Young Adult | 2011 |
[Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Prednisone; Procarbazine; Pyrimidines; Remission Induction; Treatment Outcome; Vincristine | 2012 |
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Cytarabine; Dasatinib; Dexamethasone; Doxorubicin; Female; Flow Cytometry; Follow-Up Studies; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunoglobulin Heavy Chains; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Real-Time Polymerase Chain Reaction; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Thiazoles; Vincristine; Young Adult | 2013 |
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
[Therapeutic response to pyridoxine and pyridostigmine in a paediatric case of severe peripheral and cranial polyneuropathy due to vincristine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blepharoptosis; Cranial Nerve Diseases; Daunorubicin; Diagnosis, Differential; Esotropia; Female; Guillain-Barre Syndrome; Humans; Imatinib Mesylate; Infant; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyridostigmine Bromide; Pyridoxine; Quadriplegia; Vincristine | 2015 |
Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Anthracyclines; Antigens, CD19; Antigens, CD20; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; CD79 Antigens; Female; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunoglobulin Light Chains, Surrogate; Immunoglobulin M; Immunophenotyping; Induction Chemotherapy; Male; Middle Aged; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Sialic Acid Binding Ig-like Lectin 2; Vincristine; Young Adult | 2016 |
Hypereosinophilic Syndrome as a Rare Cause of Reversible Biventricular Heart Failure.
Topics: Adult; Anticoagulants; Antineoplastic Agents; Bone Marrow Examination; Echocardiography; Heart Failure; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Mutation; Oncogene Proteins, Fusion; Prednisone; Receptor, Platelet-Derived Growth Factor alpha; Thrombosis; Treatment Outcome; Warfarin | 2017 |
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adult; Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Humans; Imatinib Mesylate; Incidence; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors: a patient with dermatofibrosarcoma protuberans and successful desensitization management.
Topics: Adult; Antineoplastic Agents; Dermatofibrosarcoma; Desensitization, Immunologic; Dose-Response Relationship, Drug; Drug Hypersensitivity Syndrome; Humans; Imatinib Mesylate; Male; Prednisone; Skin Neoplasms | 2018 |
CASE OF DEVELOPMENT OF NON-HODGKIN'S MALIGNANT LYMPHOMA ON THE BACKGROUND OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WHO SUFFERED OF THE CHORNOBYL ACCIDENT.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chernobyl Nuclear Accident; Cyclophosphamide; Doxorubicin; Environmental Exposure; Female; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, T-Cell; Middle Aged; Prednisone; Radiation Exposure; Radiation, Ionizing; Treatment Outcome; Ukraine; Vincristine | 2018 |
Imatinib-induced irreversible interstitial lung disease: A case report.
Topics: Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Prednisone; Protein Kinase Inhibitors; Pyrimidines; Tomography, X-Ray Computed | 2019 |
Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Imatinib Mesylate; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymph Nodes; Lymphoproliferative Disorders; Male; Prednisone; Protein Kinase Inhibitors; Splenomegaly; Tomography, X-Ray Computed; Vincristine | 2019 |
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Dasatinib; Female; Humans; Imatinib Mesylate; Induction Chemotherapy; Male; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies | 2020 |
Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Daunorubicin; Fusion Proteins, bcr-abl; Genetic Testing; Humans; Imatinib Mesylate; Male; Mutation; Pharmacogenomic Variants; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protein Kinase Inhibitors; Remission Induction; Treatment Outcome; Vincristine; Young Adult | 2021 |
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone.
Topics: Animals; Dog Diseases; Dogs; Imatinib Mesylate; Myeloproliferative Disorders; Prednisone; Vinblastine | 2022 |